InvestorsHub Logo
Followers 8
Posts 375
Boards Moderated 0
Alias Born 07/17/2006

Re: None

Wednesday, 12/06/2023 6:18:36 PM

Wednesday, December 06, 2023 6:18:36 PM

Post# of 2839
Dr. Alvarez comments about the Sickle Cell study at U of Washington and the Pancreatic Study are misleading. Aphexda is THE DRUG being studied in both which he failed to mention. In fact, he refers to Aphexda as one of two drugs being studied. He said "the company has two Phase 2 drugs, one for sickle cell disease [SCD], working in collaboration with Washington University in St. Louis, and AGI-134 medication for treating Solid Tumors. Additionally, BLRX is researching Phase 1 with a drug to treat Pancreatic Cancer in partnership with Columbia University"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLRX News